Emergency Medicine Doctors in Willmar, MN Accepting Medicare

3 Emergency Medicine doctors found. Showing 1 - 3

Dr. Scott Matthew Abrams, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000    Fax: 320-231-5067

Kenneth M Flowe, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Becker Ave Sw, Willmar, MN 56201 Phone: 320-235-4543

Dr. William Michael Doyle, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Becker Ave Sw, Willmar, MN 56201 Phone: 320-231-4560

News Archive

Longevity research till date may be riddled with flaws: Study

Research over the last decade showing that proteins called sirtuins can increase lifespan is deeply flawed, according to a new study in Nature that debunks prior claims of a direct causal link.

SIRT1 protein necessary for telomere elongation and genome integrity during cell reprogramming

Cell reprogramming converts specialised cells such as nerve cells or skin cells towards an embryonic stem cell state. This reversal in the evolutionary development of cells also requires a reversal in the biology of telomeres, the structures that protect the ends of chromosomes; whilst under normal conditions telomeres shorten over time, during cell reprogramming they follow the opposite strategy and increase in length.

Vuvuzela unhealthy in more ways than one: Study

According to health experts, Vuvuzelas - the horns used by football fans celebrating last year's World Cup - not only cause noise pollution but may also spread diseases. According to a new study published in PLoS One journal it is seen that a short burst on the instrument creates a spittle shower similar to a sneeze, travelling at a four million droplets a second. Authors write that in crowded venues one person blowing a Vuvuzela could infect many others with airborne illness like the flu or TB.

USPTO grants KL4 surfactant combination product patent to Discovery Labs

Discovery Laboratories, Inc. has been notified that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent Number 7,863,241 titled "Compositions for Treatment and Prevention of Pulmonary Conditions." The patent provides broad coverage for compositions that employ a combination of certain pulmonary surfactants with a broad array of protease inhibitors, administered as either a liquid or aerosol, for treating pulmonary inflammation.

Read more Medical News

› Verified 6 days ago